The profile of health technologies incorporated in SUS during 2012- 2019: who are the mainly demanders?

Abstract

Health technologies have revolutionized medical care and health management. The National
Commission for the Incorporation of Technologies in the SUS (Conitec) is the Ministry of Health’s body
that advises on the incorporation, exclusion or alteration of new technologies in the Unified Health System
(SUS). This study aimed to describe the profile of technologies incorporated in the SUS between January 1,
2012 and September 30, 2019. Data were collected on the Conitec website. Statistical analysis used Pearson’s

chi-square test and Fisher’s exact test. The results show that 380 technologies were incorporated, with medi-
cation prevailing (46.6%). In relation to the plaintiffs, those of internal origin surpassed the others (82.4%),

mainly secretariats of the Ministry of Health (p<0.001). Infectious and Parasitic Diseases (PIDs) were the
most benefited (20.3%), with emphasis on HIV (Human Immunodeficiency Virus). Most of the incorporated
technologies underwent public consultation (p<0.001). It is concluded that the profile of the incorporated
technologies are mainly medicines, by internal demand, with indication for PIDs and, above all, for HIV.
Medicines continue to be the focus of requests and internal demands have gained more space in this scenario.